4.8 Article

Evolutionary Dynamics of Complex Networks of HIV Drug-Resistant Strains: The Case of San Francisco

Journal

SCIENCE
Volume 327, Issue 5966, Pages 697-701

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1180556

Keywords

-

Funding

  1. National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI041935, P30-AI27763]
  2. Natural Sciences and Engineering Research Council of Canada
  3. Mathematics of Information Technology and Complex Systems
  4. John Simon Guggenheim Foundation
  5. National Academies Keck Foundation
  6. Semel Institute for Neuroscience Human Behavior
  7. NCRR [K24RR024369]
  8. AHRQ [R18-HS017784]
  9. AHRQ [541399, 5R18HS017784-02] Funding Source: Federal RePORTER
  10. Div Of Biological Infrastructure
  11. Direct For Biological Sciences [0832858] Funding Source: National Science Foundation

Ask authors/readers for more resources

Over the past two decades, HIV resistance to antiretroviral drugs (ARVs) has risen to high levels in the wealthier countries of the world, which are able to afford widespread treatment. We have gained insights into the evolution and transmission dynamics of ARV resistance by designing a biologically complex multistrain network model. With this model, we traced the evolutionary history of ARV resistance in San Francisco and predict its future dynamics. By using classification and regression trees, we identified the key immunologic, virologic, and treatment factors that increase ARV resistance. Our modeling shows that 60% of the currently circulating ARV-resistant strains in San Francisco are capable of causing self-sustaining epidemics, because each individual infected with one of these strains can cause, on average, more than one new resistant infection. It is possible that a new wave of ARV-resistant strains that pose a substantial threat to global public health is emerging.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available